Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 427

    Jitendra Singh lays foundation stone for biotech park in J-K

    Jitendra Singh lays foundation stone for biotech park in J-K

    Ruby Khatun Khatun17 May 2017 12:50 PM IST
    Jammu: Union minister Jitendra Singh laid the foundation stone for north Indias second Biotech park in Jammu and Kashmirs Kathua district, saying it...
    Dr Reddys Laboratories launches generic hepatitis C drug in India

    Dr Reddys Laboratories launches generic hepatitis C drug in India

    Ruby Khatun Khatun17 May 2017 12:50 PM IST
    New Delhi: Dr Reddys Laboratories said it has launched a generic version of Sofosbuvir 400 mg and Velpatasvir 100 mg fixed-dose combination, indicated...
    Glenmark Pharma anti-myeloma drug gets clinical trial nod from USFDA

    Glenmark Pharma anti-myeloma drug gets clinical trial nod from USFDA

    Ruby Khatun Khatun17 May 2017 12:34 PM IST
    New Delhi: The US health regulator has cleared Glenmark Pharma's investigational new drug application to initiate phase one study of GBR 1342, a...
    Alembic Pharmaceuticals cholesterol drug gets US FDA nod

    Alembic Pharmaceuticals cholesterol drug gets US FDA nod

    Ruby Khatun Khatun16 May 2017 12:19 PM IST
    New Delhi: Alembic Pharmaceuticals has received approval from the US health regulator for Fenofibric Acid Delayed-Release capsules used for lowering...
    Rajasthan to get nation’s first Indian Medical Device Park

    Rajasthan to get nation’s first Indian Medical Device Park

    Ruby Khatun Khatun16 May 2017 12:19 PM IST
    New Delhi: Managing Director of Rajasthan State Industrial Development & Investment Corporation Limited (RIICO) Mugdha Sinha announced that there...
    Suven Life Sciences Q4 net profit up 7.8% at Rs 40 cr

    Suven Life Sciences Q4 net profit up 7.8% at Rs 40 cr

    Ruby Khatun Khatun16 May 2017 12:08 PM IST
    New Delhi: Drug firm Suven Life Sciences reported 7.8 per cent increase in standalone net profit at Rs 40.06 crore for the fourth quarter ended March...
    GlaxoSmithKline Consumer Healthcare Ltd Q4 net profit up 8 per cent at Rs 175 cr

    GlaxoSmithKline Consumer Healthcare Ltd Q4 net profit up 8 per cent at Rs 175 cr

    Ruby Khatun Khatun16 May 2017 12:07 PM IST
    New Delhi: GlaxoSmithKline Consumer Healthcare Ltd reported a 8.42 per cent increase in standalone net profit at Rs 175.88 crore for the fourth...
    USFDA issues 4 observations for Torrent Pharmaceuticals Indrad plant

    USFDA issues 4 observations for Torrent Pharmaceuticals Indrad plant

    Ruby Khatun Khatun15 May 2017 12:52 PM IST
    New Delhi: Drug firm Torrent Pharmaceuticals said the US health regulator has issued four observations after inspection of its Indrad facility in...
    Dr Lal PathLabs posts Q4 net profit at Rs 31 cr

    Dr Lal PathLabs posts Q4 net profit at Rs 31 cr

    Ruby Khatun Khatun15 May 2017 12:51 PM IST
    New Delhi: Diagnostic chain Dr Lal PathLabs reported a consolidated net profit of Rs 30.99 crore for the March quarter.The company had posted a net...
    Pfizers pneumonia vaccine now part of immunization programme

    Pfizer's pneumonia vaccine now part of immunization programme

    Ruby Khatun Khatun15 May 2017 11:09 AM IST
    Drug firm Pfizer said its pneumonia vaccine PCV 13 has been included in India's immunisation programme in select states.The company's 13-valent...
    Boston Scientific Announces Positive European Registry Results For WATCHMAN, Left Atrial Appendage Closure Device

    Boston Scientific Announces Positive European Registry Results For WATCHMAN, Left Atrial Appendage Closure Device

    Ruby Khatun Khatun15 May 2017 10:56 AM IST
    MARLBOROUGH: Boston Scientific announced positive safety and efficacy rates of the WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device from the...
    HC stops Natco Pharma from exporting generic of Bayers cancer drug

    HC stops Natco Pharma from exporting generic of Bayers cancer drug

    Ruby Khatun Khatun15 May 2017 10:52 AM IST
    New Delhi: The Delhi High Court put on hold an order of its single judge allowing Indian generic drug makers to make, sell and export patented...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok